Outcomes for depression and anxiety in primary care and details of treatment: a naturalistic longitudinal study by Prins, Marijn A et al.
RESEARCH ARTICLE Open Access
Outcomes for depression and anxiety in primary
care and details of treatment: a naturalistic
longitudinal study
Marijn A Prins
1, Peter FM Verhaak
1,2*, Mirrian Hilbink-Smolders
3, Peter Spreeuwenberg
1, Miranda GH Laurant
3,
Klaas van der Meer
2, Harm WJ van Marwijk
4, Brenda WJH Penninx
5,6,7 and Jozien M Bensing
1,8
Abstract
Background: There is little evidence as to whether or not guideline concordant care in general practice results in
better clinical outcomes for people with anxiety and depression. This study aims to determine possible associations
between guideline concordant care and clinical outcomes in general practice patients with depression and anxiety,
and identify patient and treatment characteristics associated with clinical improvement.
Methods: This study forms part of the Netherlands Study of Depression and Anxiety (NESDA).
Adult patients, recruited in general practice (67 GPs), were interviewed to assess DSM-IV diagnoses during baseline
assessment of NESDA, and also completed questionnaires measuring symptom severity, received care, socio-
demographic variables and social support both at baseline and 12 months later. The definition of guideline
adherence was based on an algorithm on care received. Information on guideline adherence was obtained from
GP medical records.
Results: 721 patients with a current (6-month recency) anxiety or depressive disorder participated. While patients
who received guideline concordant care (N = 281) suffered from more severe symptoms than patients who
received non-guideline concordant care (N = 440), both groups showed equal improvement in their depressive or
anxiety symptoms after 12 months. Patients who (still) had moderate or severe symptoms at follow-up, were more
often unemployed, had smaller personal networks and more severe depressive symptoms at baseline than patients
with mild symptoms at follow-up. The particular type of treatment followed made no difference to clinical
outcomes.
Conclusion: The added value of guideline concordant care could not be demonstrated in this study. Symptom
severity, employment status, social support and comorbidity of anxiety and depression all play a role in poor
clinical outcomes.
Background
Depression and anxiety are common mental disorders
which cause considerable emotional and physical suffer-
ing, often resulting in severe disability [1-5]. Primary
care settings have become the principal site for treating
depressive and anxiety disorders [3,6] and quality of
care for anxiety and depression seems to be moderate
or poor [7-10].
Over the past decade, many evidence-based guidelines
have been developed [11]. However, little is known
about the effects of their application on clinical care
outcomes [12]. Implementation of evidence-based clini-
cal guidelines has been advocated as a way of improving
detection and treatment of common mental disorders
and reducing variations in health care [13]. Guidelines
specify low and high intensity psychological and phar-
macological interventions with proven effectiveness. A
stepped care approach (preference for the least restric-
tive and least costly interventions) has been advocated.
Collaborative care (integration of generalist and
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[14]. In the Netherlands, the Dutch College of General
Practitioners (DCGP) issued evidence-based general
practice guidelines for depression and anxiety [15,16],
which are widely accepted and play a prominent role in
continuing professional development programmes for
medical practitioners[17]. These guidelines follow the
international accepted state of the art and are compar-
able with British [14] and American [18] guidelines.
There is some evidence that guideline concordant
treatment is positively associated with improvements in
patients with depressive [19] and anxiety disorders [20].
However, randomised controlled trials designed to
improve outcomes for anxiety and depression in primary
care, by structured implementation of evidence-based
guidelines, show mixed results [21]. In addition, sys-
tematic reviews report little effect of guideline imple-
mentation [12,22]. The Hampshire Depression Project, a
major trial on implementing guideline concordant care,
could not show improvements in diagnosis of or recov-
ery from depression [23]. Croudace et al. [24] did not
find an effect of guideline implementation on detection
and outcome for mental disorders either. However,
these studies did not analyse patient characteristics
regarding their possible benefit from guideline concor-
dant care. Furthermore, no distinction was made
between the various types of care (psychological inter-
ventions, pharmacological interventions or referral).
Although clinical severity and treatment adequacy play
a role in symptomatic improvement and full recovery
from a depressive episode, recovery also seems to be
influenced by social support, education level, age, (un)
employment and non-depressive psychopathology
[25-29]. For anxiety disorders, a good outcome was pre-
dicted by mild symptoms, high education level and
being employed, as well as male gender and later onset
[25,30,31], while comorbidity with major depression
worsened clinical outcomes in a 12-year study [32].
Therefore, whether or not guideline concordant care
in general practice will improve clinical outcomes in
anxiety and depression patients with specific characteris-
tics or with specific interventions has yet to be demon-
strated. Consequently, the following questions will be
addressed:
1) Do primary care patients with a current anxiety or
depressive disorder, who received guideline concordant
care, show greater clinical improvement after one year
than patients who did not receive care in accordance
with the guidelines?
2) Which patient characteristics are associated with
particular clinical outcomes after one year?
3) Which interventions are associated with particular
clinical outcomes after one year?
Methods
Setting and recruitment
Data were collected in the Netherlands Study of Depres-
sion and Anxiety (NESDA, http://www.nesda.nl).
NESDA is a multi-site naturalistic cohort study designed
to measure the long-term course and consequences of
depressive and anxiety disorders [33]. For this study, pri-
mary care data were used.
Adult patients (18-65 years old) were recruited from 67
GPs (21practices), selected based on their use of electro-
nic medical record (EMR) systems. Patients who attended
their GP in the last 4 months, irrespective of the reason
for consultation, were sent a questionnaire consisting of
the Kessler-10 (K-10) [34], with five additional questions
to screen for depressive or anxiety disorders. Nearly half
of the questionnaires returned were screen-positive (K-
10 score of 20 or higher or a positive score on any of the
additional anxiety questions). Women and older people
were more likely to return the questionnaire, but there
were no differences in psychopathology between respon-
ders and non-responders [33,35]. These people were
interviewed by phone with the short form of the Compo-
site Interview Diagnostic Instrument (CIDI). Patients
w h of u l f i l l e dt h eC I D I - s h o r tf o r mc r i t e r i af o rac u r r e n t
(6-month recency) depressive or anxiety disorder, were
asked to participate in NESDA and were invited for a
baseline assessment. For a detailed summary of the sam-
pling procedure, see Figure 1.
Measurements
During baseline assessment, all patients were inter-
viewed and completed questionnaires to collect detailed
socio-demographic data including age, gender, education
level (3 levels), employment status, income, marital and
partnership status, and personal network size. The CIDI
interview, WHO Lifetime Version 2.1 was conducted
which identified 743 patients who met DSM-IV criteria
[36] for a current depressive (Major Depressive Disorder
(MDD), dysthymia) or anxiety disorder (generalised
anxiety disorder, social phobia, panic disorder, agora-
phobia). Since 22 patients refused to give informed con-
sent for the use of their EMR, ultimately 721 patients
were included in this study.
One year after inclusion, each participant received a
questionnaire containing the most important self-report
instruments (measuring severity of depression and anxi-
ety, see below) to determine the course of anxiety and
depression symptoms.
Actual GP care: guideline concordant care versus non-
guideline concordant care
I n f o r m a t i o no nt h ed e l i v e r yo fc a r eg i v e nt op a t i e n t s
with a current anxiety or depression diagnosis (as
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Data were extracted from the year prior to inclusion in
the NESDA study to one year after inclusion. The fol-
lowing data were collected for each patient included in
the study,: number and type of contacts, International
Classification of Primary Care (ICPC) codes [37], pre-
scribed medication (type and dose), duration of pre-
scription, and referrals. Our earlier NESDA paper [38]
described the degree to which GPs adhered to the evi-
dence-based DCGP clinical depression and anxiety
guidelines in the delivery of care for their anxiety and
depression patients [15,16]. Based on the care they had
received, patients were divided into two groups, i.e.
patients who had received 1) guideline concordant care,
or 2) non-guideline concordant care. The algorithm for
guideline concordant care is:
› PSYCHOLOGICAL SUPPORT including at least
five consultations in the 15 weeks following docu-
mentation of diagnosis
OR
› COUNSELLING (only applicable to GP depres-
sion care)
OR
› PRESCRIPTION OF ANTIDEPRESSANT MEDI-
CATION including evaluation after six weeks of
prescription and minimal duration of five months or
cessation in case of no response
OR
› REFERRAL TO MENTAL HEALTH SPECIALIST
Patients fulfilling one of the criteria (receiving psycho-
logical support, counselling, AD-medication or referral,
according to the specifications given above) are consid-
ered to have received guideline concordant care. 50% of
patients with depression and anxiety disorders received
guideline concordant care, mainly counselling, medica-
tion or referral. 42% of patients with depression only
received guideline concordant care, mainly in the form
of counselling or referral. Only 27% of patients with
anxiety disorders only received guideline concordant
care, mainly in the form of referral.
This algorithm is necessarily a simplified version of
treatment recommendations described in various guide-
lines. It only takes account of whether a treatment is in
place, without including the content of the interventions
or the conditions under which treatment occurs. This is
due to lack of data e.g. regarding severity of symptoms
during GP contact or treatments already tried in the
past.
Patients fell into the non-guideline concordant care
group if they did not fulfil any of the abovementioned
criteria (i.e. if they did not receive counselling, sufficient
pharmacological treatment or referral).
Clinical outcome measures
Clinical status was measured by the 30-item Inventory
of Depressive Symptoms self-report (IDS-SR), which
measures the severity of depressive symptoms, and has
shown highly acceptable psychometric properties [39],
as well as the 21-item Beck Anxiety Inventory (BAI),
measuring anxiety symptoms [40]. Total scores of the
IDS-SR and BAI could range from 0 to 84 and 0 to 63
respectively, where high scores indicate more (severe)
symptoms. These clinical outcome measures were mea-
sured at the baseline assessment of NESDA (T0) and at
one year follow-up (T1).
Statistical analyses
First, c
2 and t-test for independent samples were used
to compare patient characteristics of those who received
guideline concordant care with those who received non-
guideline concordant care.
Secondly, using MLwiN software, a multilevel repeated
measures analysis was undertaken to test whether
improvements in symptom severity were statistically sig-
nificantly different between follow-up and baseline.
Since data were grouped (clustered) by GPs and prac-
tices, a random intercept was included in the model to
adjust for possible differences resulting from this clus-
tering. All values were corrected for age, gender,
Figure 1 Recruitment flow of NESDA respondents in the
primary care sample.
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vel model takes all available data into account (the
paired samples that had completed the questionnaires
on both occasions, as well as the unpaired data of those
patients who only completed the questionnaires at base-
line). For the outcome measures on baseline and follow-
up, adjusted means and standard errors were calculated
for both treatment groups. To compare differences in
trends from baseline to follow-up between the two care
groups, differences in means were tested using Wald
statistics (df = 1). Trends were considered significant if
Chi-square was > 3.85 (P < .05).
Thirdly, multilevel regression analyses were performed
to model associations between socio-demographic char-
acteristics, severity scores at baseline and specific types
of treatment (counselling/psychological support, antide-
pressants, referral), with clinical severity at follow-up as
the outcome variable. Fixed and random parameter esti-
mates and their standard errors (SE) were calculated.
Finally, multilevel logistic regression analyses were
performed to model associations between different
patient characteristics and (still) having moderate or
severe anxiety or depressive symptoms at follow-up.
Socio-demographic characteristics were entered, fol-
lowed by social support variables and type of diagnosis.
In the last step, severity symptoms at baseline were
added to the model.
Ethical approval
The NESDA study was approved centrally by the Ethics
Review Board of the VU University Medical Center and
by local review boards of the participating institutes.
Following the provision of verbal and written informa-
tion on the study, written informed consent was
obtained from all participants.
Results
Patient characteristics: guideline concordant care versus
non-guideline concordant care
As described elsewhere [34], 281 (39%) of patients
received guideline concordant care from their GP and
440 (61%) patients received non-guideline concordant
care. There were no significant differences between the
two groups with regard to gender, age, marital status,
working status and education level (Table 1). However,
patients who received guideline concordant care were
more likely to suffer from comorbidity of both anxiety
and depressive disorders, than they were to suffer from
an anxiety disorder only, compared with patients who
received non-guideline concordant care. At baseline,
patients who received guideline concordant care had on
average significantly higher severity scores than the non-
guideline concordant care group.
At follow-up, 139 patients (19%) had been lost as a
result of attrition. Compared with non-completers, com-
pleters were older (45.7 vs. 41.5), more highly educated,
and reported less severe anxiety (15.2 vs. 20.5) and
depression (26.6 vs. 30.9) symptoms.
Clinical outcome and guideline adherence
The adjusted means and standard errors for the guide-
line concordant and non-guideline concordant care
Table 1 Comparisons of patients who received Guideline concordant care and Non-guideline concordant care at
baseline (T0)
Guideline concordant care, N =
281
Non-guideline concordant care, N =
440
P-value
Female gender (%) 68.0 71.6 0.30
Age in years, mean (SD) 45.0 (11.4) 44.9 (12.5) 0.89
Married/living together (%) 44.5 38.4 0.11
Working (%) 64.4 66.4 0.59
Education level (%) 0.22
Basic 7.1 10.9
Intermediate 60.9 57.3
High 32.0 31.8
Type of diagnosis (%)
Anxiety disorder(s) only 28.8 49.3 <
0.0001
Depressive disorder(s) only 22.1 19.5 0.41
Comorbidity of both depressive and anxiety
disorders
49.1 31.1 <
0.0001
Clinical outcome measures T0, mean (SD)
Severity of depressive symptoms (IDS-SR) 30.8 (12.1) 25.3 (10.7) <
0.0001
Severity of anxiety symptoms (BAI) 17.9 (11.3) 15.1 (9.5) 0.001
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presented in Table 2 for patients with at least one
depressive disorder, and in Table 3 for patients with at
least one anxiety disorder. Patients with depression
improved significantly on depressive symptoms between
T0 and T1, and patients with anxiety improved on their
anxiety symptoms (P < .001). After controlling for
patients’ age, gender, education level, baseline severity
score and clustering, patients from the non-guideline
concordant care group had improved just as much as
those from the guideline concordant care group in both
depression (6.5 resp. 8.1 points) and anxiety (2.9 resp.
4.0) levels.
Associations with socio-demographics and type of
treatment
Associations between severity of symptoms at T1 and
socio-demographics and type of treatment are presented
in Table 4.
Severity of depressive and anxiety symptoms respec-
tively at T1 (dependent variables) was significantly asso-
ciated with severity score at baseline and with
intermediate (versus high) education level both for
patients with depressive disorders and patients with
anxiety disorders. In patients with depressive disorders,
higher age was also positively associated. No significant
associations between any of the different care forms, for
either depression or anxiety, and clinical outcomes at
T1 were found.
Patient characteristics and course of anxiety and
depression
Patients who (still) had moderate or high anxiety or
depressive symptoms at follow-up (N = 213), were more
likely to be unemployed and have lower income than
patients who had low anxiety and depressive symptoms
at follow-up (N = 364) (Table 5). When social support
variables were added to the model, personal network
size was significantly associated (OR = 0.94) with the
severity of symptoms at follow-up. When the diagnosis
was added, the presence of either anxiety disorders or
depressive disorders without comorbidity decreased the
chance of having moderate or severe symptoms after
one year (comorbidity of both anxiety and depression
increased this chance). However, when severity scores
were finally added, all former associations disappeared
and only the severity of depressive symptoms was
Table 2 Differences in severity of depressive symptoms
in patients with depression (N = 423) who received
guideline concordant care (GCC) versus non-guideline
concordant care (NGCC) at baseline (T0) and after 12
months (T1)
Outcome measure T0 T1 Δ T0-T1
GCC NGCC GCC NGCC GCC
NGCC
IDS score, mean 32.9 (0.9)
a 28.5 24.8 (1.0)
a 22.0 8.1
c
(SD) (0.8)
b (0.8)
b 6.5
c
a GCC: T0 > T1 (c
2 = 68.5; p < .001)
b NGCC: T0 > T1 (c
2 = 64.9; p < .001)
c ΔT0-T1: ns
All values are corrected for age, gender, education level and baseline severity
score, and clustering within practices and GPs.
Table 3 Differences in severity of anxiety symptoms in
patients with anxiety (N = 573) who received guideline
concordant care (GCC) versus non-guideline concordant
care (NGCC) at baseline (T0) and after 12 months (T1)
Outcome
measure
T0 T1 Δ T0-
T1
GCC NGCC GCC NGCC GCC
NGCC
BAI score, mean 18.7 (0.8)
a 15.1 14.7 (0.8)
a 12.2 4.0
c 2.9
c
(SD) (0.6)
b (0.5)
b
a GCC: T0 > T1 (c
2 = 27.8; p < .001)
b NGCC: T0 > T1 (c
2 = 26.7; p < .001)
c ΔT0-T1: ns
All values are corrected for age, gender, education level and baseline severity
score, and clustering within practices and GPs.
Table 4 Multilevel regression analysis on severity of
depressive and anxiety symptoms respectively at T1 by
patient characteristics and type of treatment received in
patients with depressive (N = 322) and anxiety disorders
(N = 457)
Estimate (SE) P-value
Patients with depressive disorder(s)
Severity of depressive symptoms at T0 0.61 (0.05) < 0.0001
Female gender
a 0.85 (1.17) 0.47
Age 0.11 (0.05) 0.01
Basic education level
b 3.59 (2.12) 0.09
Intermediate education level
b 2.21 (1.12) 0.05
Counselling received 1.47 (1.51) 0.33
Antidepressants received for ≥ 5 months -2.87 (2.16) 0.18
Referred to a mental health specialist 0.84 (1.31) 0.52
Patients with anxiety disorder(s)
Severity of anxiety symptoms at T0 0.58 (0.04) < 0.0001
Female gender
a -0.23 (0.78) 0.76
Age 0.03 (0.03) 0.27
Basic education level
b 2.01 (1.37) 0.14
Intermediate education level
b 1.79 (0.78) 0.02
Psychological support received -1.43 (2.08) 0.49
Antidepressants received for ≥ 5 months -0.98 (1.59) 0.54
Referred to a mental health specialist 0.30 (0.89) 0.74
a reference category = male gender;
b reference category = high education
level
All values are corrected for clustering within practices and GPs.
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severe depressive symptoms at baseline increased the
chance of still having moderate or severe symptoms at
follow-up. Thus, patients in adverse circumstances
(unemployed, low income, small network) were more
likely to retain a moderate/high symptom level at fol-
low-up, because these were associated with higher base-
line severity, which was the best predictor for lack of
recovery at T1.
Discussion
Summary of main findings
I nt h i ss t u d yw ed e t e r m i n e dt he possible associations
between guideline concordant care and clinical out-
comes in patients with anxiety and depressive disorders
and identified patient and treatment characteristics asso-
ciated with better or worse outcomes. Patients who were
not treated in accordance with the general practice
guidelines improved on their anxiety and depressive
symptoms just as much as patients who were treated in
accordance with those guidelines. While patients with
comorbidity of both anxiety and depressive disorders,
those with smaller personal networks and the unem-
ployed were more likely to suffer from moderate or
severe symptoms after 12 months. Severity of depressive
symptoms at baseline was most strongly associated with
severity after one year. In the case of depression, older
patients and patients with an intermediate education
level (as opposed to a high education level) had more
severe symptoms after a year. In the case of anxiety,
only education level was associated with severity. Differ-
ent kinds of treatment did not result in different
outcomes.
Strengths and limitations of this study
The large sample size and the use of a prospective
design in the collection of data to assess guideline
adherence constitute the strong points of this study.
The primary care sample of NESDA is representative to
other GP attendees in the Netherlands and data for the
same patient group were gathered at baseline and at the
12 month follow-up, which facilitated longitudinal com-
parisons. Furthermore, our data could be considered
representative for “real life” treatment of depression and
anxiety in primary care.
However, the naturalistic design of the study constitu-
tes a major limitation. Participants could not be rando-
mised and baseline scores differed markedly between
the treatment groups. Even though estimated means
were corrected for scores at baseline, it is still difficult
to determine whether non-guideline concordant care is
just as effective as care in accordance with the
Table 5 Multilevel logistic regression analysis on (still) having moderate or severe depressive or anxiety symptoms at
T1 (versus having low anxiety and depressive symptoms at T1)
Step 1 Step 2 Step 3 Step 4
OR (95%- CI) OR (95%- CI) OR (95%- CI) OR (95%- CI)
Socio-demographic variables
Female gender
a 1.09 (0.73-1.62) 1.09 (0.73-1.62) 1.05 (0.70-1.58) 1.03 (0.65-1.64)
Age 1.01 (1.00-1.03) 1.01 (1.00-1.03) 1.02 (1.00-1.03) 1.02 (1.00-1.04)
Basic education level
b 1.74 (0.86-3.52) 1.59 (0.77-3.28) 1.54 (0.73-3.25) 1.00 (0.42-2.35)
Intermediate education level
b 1.50 (1.01-2.22) 1.47 (0.98-2.21) 1.50 (0.99-2.29) 1.45 (0.89-2.37)
Working 0.56 (0.38-0.84) 0.56 (0.38-0.84) 0.64 (0.42-0.97) 0.74 (0.46-1.19)
Income above modal (>2400 euro per month)
c 0.66 (0.44-0.98) 0.69 (0.44-1.07) 0.70 (0.44-1.10) 0.68 (0.40-1.16)
Social support variables
Married/living together 0.92 (0.58-1.47) 0.84 (0.52-1.36) 0.87 (0.50-1.52)
Having a partner 1.09 (0.68-1.76) 1.09 (0.67-1.78) 1.17 (0.67-2.05)
Personal network 0.94 (0.91-0.98) 0.95 (0.92-0.99) 0.98 (0.94-1.02)
Type of diagnosis
Anxiety disorder(s) only
d 0.42 (0.28-0.63) 1.27 (0.76-2.13)
Depressive disorder(s) only
d 0.37 (0.22-0.63) 0.79 (0.43-1.44)
Severity
Severity of symptoms at T0
Depressive symptoms 1.11 (1.08-1.14)
Anxiety symptoms 1.03 (1.00-1.06)
OR in bold if P < 0.05.
a reference category = male gender;
b reference category = high education level;
c reference category = less than modal (< 2400 euro per month);
d reference
category = comorbidity of both anxiety and depressive disorders.
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subgroups interfered with our results. Only a rando-
mised controlled trial can directly test and compare the
effectiveness of strategies that make care more guideline
concordant. Finally, our classification into guideline con-
cordant and non-guideline concordant care was based
on available EMR data, which means that the quality of
registration could have influenced our independent
variables.
The study was conducted in the Netherlands, which
constitutes a limitation because the (mental) health care
system in the Netherlands differs in some respects from
those in other countries. The position of the GP in the
Dutch health care system is rather prominent, because
he acts as gatekeeper to the more specialised sectors of
health care. Access to psychiatric services or other spe-
cialised mental health services is not possible without
referral by a GP. In this respect, the situation is more or
less comparable to the UK or Denmark, but far less so
to the USA, for example.
Comparison with existing literature
It seems that patients with the most severe anxiety or
depression symptoms have the highest chance of being
diagnosed and treated by their GP. This has also been
found in previous studies ([25,41-44]and [45]).
Severity of symptoms was strongly associated with
poorer clinical outcome after one year, a finding which
has also emerged in other studies [25,46,47]. We did not
find significant associations between guideline adherence
and prognosis, as was the case in [25], although Simon
et al [46] reported a significant reduction in symptoms
among recognised cases compared with non-recognised
cases after 3 months, a difference that had disappeared
after 12 months.
Based on the literature, one would expect better diag-
nosis combined with worse prognosis for more severe
depression. A 10-year follow-up study found that even
though treatment for depressed primary care patients
was ‘inadequate by psychiatric standards’, the majority
of the patients had a favourable outcome without recur-
rences [48]. There may be good reasons why GPs devi-
ate from the guidelines, and patients get better
regardless of whether their treatment is in accordance
with clinical guidelines.
Regarding patient characteristics, in line with earlier
studies [25,29], we also found that people who are more
highly educated and in work are more likely to have a
better outcome than people who are lower educated and
unemployed. We can also confirm associations of clini-
cal outcome with social support [27,29] and comorbidity
of anxiety and depressive disorders [32] found in pre-
vious studies.
Conclusion
Guideline concordant care is provided by general practi-
tioners for more severe cases of depression and anxiety.
Less severe cases improve just as much without guide-
line concordant care. In discussions on the introduction
of DSM-V, some experts have argued that mental disor-
ders in general and depression in particular have been
defined too broadly. Lichtenberg and Belmaker [49]
made an intuition based proposal for classifying types of
depression heuristically, which is adopted by Bech [50],
who distinguished primary depression (melancholia)
from depression that is secondary to stress and depres-
sion that is secondary to medical conditions (post-natal
depression, post-stroke depression, substance abuse dis-
order). Primary depression and depression secondary to
medical conditions show good dose-response reactions
to medication, which is less clear in the case of depres-
sion secondary to stress. It is possible that GPs are
more sensitive to the first and miss the latter, from
which there is a better spontaneous recovery. This
might explain our results.
Implications for future research or clinical practice
Our findings have some practical implications, as well as
implications for future research. GPs tend to follow clin-
ical guidelines more closely when managing depression
and anxiety when patients have more severe symptoms.
However, GPs could give more attention to lower edu-
cated patients with a small personal network, and to
those who are unemployed. Finally, since patients who
do not receive guideline concordant care seem to
improve just as much as those who received guideline
concordant care, further research is needed to establish
the precise reason for this. A possible line of research
might be a further elaboration of the distinction
between primary depression to which the guidelines
should be applied, and stress induced depression and
anxiety, to which a more detached attitude might be
desirable.
Acknowledgements
The authors would like to thank Stasja Draisma for her help with data
collection and preparation. The authors are also grateful to all participating
GPs and patients and the members of the NESDA primary care team.
Funding body
The infrastructure for the NESDA study (http://www.nesda.nl) is funded
through the Geestkracht program of the Netherlands Organisation for Health
Research and Development (Zon-Mw, grant number 10-000-1002) and is
supported by participating universities and mental health care organisations
(VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical
Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ
Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ
healthcare), Netherlands Institute for Health Services Research (NIVEL) and
Netherlands Institute of Mental Health and Addiction (Trimbos). Support for
data-analyses for the present study was provided under a grant from the
Health Care Efficiency Research Programme, subprogram implementation
(grant number 945-14-413).
Prins et al. BMC Psychiatry 2011, 11:180
http://www.biomedcentral.com/1471-244X/11/180
Page 7 of 9Author details
1NIVEL, Netherlands Institute for Health Services Research, (Postbus 1568),
Utrecht, (3500 BN), the Netherlands.
2Dep. of General Practice, University
Medical Centre Groningen, (Postbus 30001), Groningen (9700 RB), the
Netherlands.
3Scientific Institute for Quality of Healthcare, Radboud
University Nijmegen Medical Centre, (Postbus 9101, 114) Nijmegen, (6500
HB) the Netherlands.
4Department of General Practice, VU University Medical
Center, (Postbus 7057), Amsterdam (1007 MB), the Netherlands.
5Department
of Psychiatry/EMGO Institute/Neuroscience Campus Amsterdam, VU
University Medical Center, (A.J. Ernststraat 887) Amsterdam, 1081 HL the
Netherlands.
6Department of Psychiatry, Leiden University Medical Center,
(Postbus 9600), Leiden, (2300 RC), the Netherlands.
7Department of
Psychiatry, University Medical Center Groningen, (Postbus 11120), Groningen,
(9700 CC), the Netherlands.
8Department of Clinical and Health Psychology,
Utrecht University, (Postbus 80140), Utrecht, (3508 TC), the Netherlands.
Authors’ contributions
MP took part in data collection in GPs’ medical records, analysed the data
and wrote the first draft.
PV participated in the original design of the NESDA study, designed this
particular study and obtained funding for it, supervised analysis and writing
and wrote the final draft. MS took part in data collection from GPs’ medical
records and commented on each of the drafts. PS did the multilevel
statistical analysis and commented on several drafts. ML collaborated in the
design of this particular study and commented on several drafts.
KvdM participated in NESDA, supervised MP’s work as one of her PhD
supervisors and commented on several drafts. HvM participated in NESDA
and commented on several drafts. BP is principal investigator of NESDA and
commented on several drafts. JB supervised MP’s work as first supervisors of
her PhD and commented on several drafts.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 July 2011 Accepted: 18 November 2011
Published: 18 November 2011
References
1. Alonso J, Codony M, Kovess V, Angermeyer MC, Katz SJ, Haro JM, et al:
Population level of unmet need for mental healthcare in Europe. Br J
Psychiatry 2007, 190:299-306.
2. Andrews G, Henderson S: Unmet need in psychiatry. Problems, resources,
responses. Cambridge: Cambridge University Press; 2000.
3. Bijl RV, Ravelli A: Current and residual functional disability associated with
psychopathology: findings from the Netherlands Mental Health Survey
and Incidence Study (NEMESIS). Psychol Med 2000, 30:657-668.
4. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al: The
epidemiology of major depressive disorder. Results from the National
Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
5. Bijl RV, Ravelli A: Psychiatric morbidity, service use, and need for care in
the general population: results of the Netherlands mental health survey
and incidence study. Am J Public Health 2000, 90:602-607.
6. Wolf NJ, Hopko DR: Psychosocial and pharmacological interventions for
depressed adults in primary care: a critical review. Clin Psychol Rev 2008,
28:131-161.
7. Young AS, Klap R, Sherbourne CD, Wells KB: The quality of care for
depressive and anxiety disorders in the United States. Arch Gen Psychiatry
2001, 58:55-61.
8. Stein MB, Sherbourne CD, Craske MG, Means-Christensen A, Bystritsky A,
Katon W, et al: Quality of care for primary care patients with anxiety
disorders. Am J Psychiatry 2004, 161:2230-2237.
9. Van Os TW, van den Brink RH, van der Meer K, Ormel J: The care provided
by general practitioners for persistent depression. Eur Psychiatry 2006,
21:87-92.
10. Mauskopf JA, Simon GE, Kalsekar A, Nimsch C, Dunayevich E, Cameron A:
Nonresponse, partial response, and failure to achieve remission:
humanistic and cost burden in major depressive disorder. Depress Anxiety
2008, 26(1):83-97.
11. Grol R: Successes and failures in the implementation of evidence-based
guidelines for clinical practice. Med Care 2001, 39(Suppl 2):46-54.
12. Worrall G, Chaulk P, Freake D: The effects of clinical practice guidelines
on patient outcomes in primary care: a systematic review. Can Med
Assoc 1997, 156:1705-1712.
13. Cornwall PL, Scott J: Which clinical practice guidelines for depression? An
overview for busy practitioners. Br J Gen Pract 2000, 50:908-911.
14. National Collaborating Centre for Mental Health (NCCMH. [http://www.
nccmh.org.uk/].
15. Nederlands Huisartsen Genootschap: NHG Standaard Depressieve stoornis
(depressie) [Dutch college of general practitioners, Practical guideline
Depressive disorder (depression)]. 2003 [http://nhg.artsennet.nl/
kenniscentrum/k_richtlijnen/k_nhgstandaarden/Samenvattingskaartje-
NHGStandaard/M44_svk.htm], [Online]. [cited 2007 March 2].
16. Nederlands Huisartsen Genootschap: NHG Standaard Angststoornis
(angst) [Dutch college of general practitioners, Practical guideline
Anxiety disorder]. 2004 [http://nhg.artsennet.nl/kenniscentrum/
k_richtlijnen/k_nhgstandaarden/Samenvattingskaartje-NHGStandaard/
M62_svk.htm], [Online]. [cited 2007 March 2].
17. Burgers JS, Grol RPTM, Zaat JOM, Spies TH, van der Bij AK, Mokkink HGA:
Characteristics of effective clinical guidelines for general practice. Br J
Gen Practice 2003, 53:15-19.
18. American Psychiatric Association Practice Guidelines. [http://
psychiatryonline.org].
19. Von Korff M, Goldberg D: Improving outcomes in depression: the whole
process of care needs to be enhanced. BMJ 2001, 323:948-949.
20. Van Boeijen CA, van Oppen P, van Balkom AJ, Visser S, Kempe PT,
Blankenstein N, et al: Treatment of anxiety disorders in primary care
practice: a randomised controlled trial. Br J Gen Pract 2005, 55:763-769.
21. Baldwin DS: Evidence-based guidelines for anxiety disorders: can they
improve clinical outcomes? CNS Spectr 2006, 11:34-39.
22. Gilbody S, Whitey P, Grimshaw J, Thomas R: Educational and
organizational interventions to improve the management of depression
in primary care. A systematic review. JAMA 2003, 289:3145-3151.
23. Thompson C, Kinmonth A, Stevens L, Peveler RC, Stevens A, Ostler KJ, et al:
Effects of a clinical-practice guideline and practice-based education on
detection and outcome of depression in primary care: Hampshire
Depression Project randomised controlled trial. Lancet 2000, 355:185-191.
24. Croudace T, Evans J, Harrison G, Sharp DJ, Wilkinson E, McCann G, et al:
Impact of the ICD-10 Primary Health Care (PHC) diagnostic and
management guidelines for mental disroders on detection and outcome
in primary care. Br J Psychiatry 2003, 182:20-30.
25. Ronalds C, Creed F, Stone K, Webb S, Tomenson B: Outcome of anxiety
and depressive disorders in primary care. Br J Psychiatry 1997,
171:427-433.
26. Brown C, Schulberg HC, Prigerson HG: Factors associated with
symptomatic improvement and recovery from major depression in
primary care patients. Gen Hosp Psychiatry 2000, 22:242-250.
27. Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA: Determinants
of persistence of major depressive episodes in the general population.
Results from the Netherlands Mental Health Survey and Incidence Study
(NEMESIS). J Affect Disord 2004, 81:231-240.
28. Enns MW, Cox BJ: Psychosocial and clinical predictors of symptom
persistence vs remission in major depressive disorder. Can J Psychiatry
2005, 50:769-777.
29. Gilchrist G, Gunn J: Observational studies of depression in primary care:
what do we know? BMC Fam Pract 2007, 11:8-28.
30. Rubio G, López-Ibor JJ: Generalized anxiety disorder: a 40-year follow-up
study. Acta Psychiatr Scand 2007, 115:372-379.
31. Francis JL, Weisberg RB, Dyck IR, Culpepper L, Smith K, Orlando Edelen M,
et al: Characteristics and course of panic disorder and panic disorder
with agoraphobia in primary care patients. Prim Care Companion J Clin
Psychiatry 2007, 9:173-179.
32. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, et al:
Influence of psychiatric comorbidity on recovery and recurrence in
generalized anxiety disorder, social phobia, and panic disorder: a 12-
year prospective study. Am J Psychiatry 2005, 162:1179-1187.
33. Penninx BWJH, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P,
et al: The Netherlands Study of Depression and Anxiety (NESDA):
Prins et al. BMC Psychiatry 2011, 11:180
http://www.biomedcentral.com/1471-244X/11/180
Page 8 of 9rationale, objectives and methods. Int J Methods Psychiatr Res 2008,
17:121-140.
34. Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al:
Screening for serious mental illness in the general population. Arch Gen
Psychiatry 2003, 60:184-189.
35. Van der Veen WJ, van der Meer K, Penninx BW: Screening for depression
and anxiety: analysis of cohort attrition using general practice data on
psychopathology. Int J Methods Psych Res .
36. American Psychiatric Association: Diagnostic and statistic manual of
mental disorders. Washington;, 4 2001.
37. Lamberts H, Wood M: International Classification of Primary Care (ICPC).
Oxford: Oxford University Press; 1990.
38. Smolders M, Laurant M, Verhaak PFM, Prins MA, van Marwijk HWJ,
Penninx BWJH, et al: Adherence to evidence-based guidelines for
depression and anxiety disorders is associated with recording of the
diagnosis. Gen Hosp Psychiatry 2009, 31:460-469.
39. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH: The Inventory of
Depressive Symptomatology (IDS): psychometric properties. Psychol Med
1996, 26:477-486.
40. Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical
anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
41. Wittchen HU: Generalized anxiety disorder: prevalence, burden, and cost
to society. Depress Anxiety 2002, 16:162-171.
42. Dowrick C, Buchan I: Twelve month outcome of depression in general
practice: does detection or disclosure make a difference? BMJ 1995,
311:1274-1276.
43. 1998 Goldberg D, Privett M, Ust++n TB, Simon G, Linden M: The effects of
detection and treatment of depression on the outcome of major
depression in primary care: a naturalistic study in 15 cities. British Journal
of General Practice 1998, 48:1840-1844.
44. Hyde J, Evans J, Sharp D, Croudace T, Harrison G, Lewis G, et al: Deciding
who gets treatment for depression and anxiety: a study of consecutive
GP attenders. Br J Gen Pract 2005, 55:846-853.
45. Simon GE, Goldberg D, Tiemens BG, Ustun TB: Outcomes of recognized
and unrecognized depression in an international primary care study.
Gen Hosp Psychiatry 1999, 21:97-105.
46. Licht-Strunk E, van Marwijk HWJ, Hoekstra T, Twisk JWR, de Haan M,
Beekman ATF: Outcome of depression in later life in primary care:
longitudinal cohort study with three years’ follow-up. BMJ 2009, 338:
a3079.
47. Spijker J, Bijl RV, de Graaf R, Nolen WA: Determinants of poor 1-year
outcome of DSM-III-R major depression in the general population:
results of the Netherlands Mental Health Survey and Incidence Study
(NEMESIS). Acta Psychiatr Scand 2001, 103:122-130.
48. Van Weel-Baumgarten EM, van den Bosch WJ, Hekster YA, van den
Hoogen HJ, Zitman FG: Treatment of depression related to recurrence:
10-year follow-up in general practice. J Clin Pharm Ther 2000, 25:61-66.
49. Lichtenberg P, Belmaker RH: Subtyping major depressive disorder.
Psychother. Psychosom 2010, 79:131-135.
50. Bech P: Struggle for subtypes im primary and secondary depression and
their mode-specific treatment or healing. Psychother Psychosom 2010,
79:331-338.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/11/180/prepub
doi:10.1186/1471-244X-11-180
Cite this article as: Prins et al.: Outcomes for depression and anxiety in
primary care and details of treatment: a naturalistic longitudinal study.
BMC Psychiatry 2011 11:180.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Prins et al. BMC Psychiatry 2011, 11:180
http://www.biomedcentral.com/1471-244X/11/180
Page 9 of 9